Optimizing Therapy and Management of Neurogenic Bladder

被引:0
|
作者
Ginsberg, David [1 ,2 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Urol, Los Angeles, CA USA
[2] Rancho Los Amigos Natl Rehabil Ctr, Dept Urol, Downey, CA USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2013年 / 19卷 / 09期
关键词
QUALITY-OF-LIFE; INTRAVESICAL OXYBUTYNIN; SACRAL NEUROMODULATION; DETRUSOR OVERACTIVITY; URINARY-INCONTINENCE; EFFICACY; DYSFUNCTION; ONABOTULINUMTOXINA; ANTIMUSCARINICS; SYMPTOMS;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Clinicians managing patients with neurogenic bladder (NGB) and neurogenic detrusor overactivity (NDO) are faced with a myriad of complex choices when deciding on appropriate medical and/or surgical interventions to relieve bothersome symptoms associated with NGB and NDO, especially urinary incontinence. Therapies must provide maximum benefits while minimizing patients' risk for adverse events. A thorough knowledge and understanding of available and emerging medical and surgical treatment options for NGB/NDO is vital to assist clinicians in choosing appropriate treatment pathways and optimize response to therapy and individual outcomes.
引用
收藏
页码:S197 / S204
页数:8
相关论文
共 50 条